Observational studyJAMA oncology2022

SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer Agents.

Charlotte Fenioux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.